Asclepius MedTech Limited
Revolutionising Pre- and Post-Operative Surgical Assessment by Unleashing and Unlocking the Power of Data
Our Mission is to improve the quality of life and outcomes for patients undergoing lower abdominal surgeries, tackle the morbidity associated with these major surgeries and positively impact millions of patients’ lives.
We aim to deliver a sustainable, scalable and patient acceptable advanced remote patient monitoring platform that will simplify and improve pre- and post-operative surgical assessment.
The need for improved surgical care is a health care imperative for every hospital organisation in every market
Over 310 million major surgeries are performed each year with around 50 million in USA and 20 million in Europe and the demand is increasing due to earlier detection and an ageing population. Surgical complications and readmissions post-surgery remain a key concern for surgical and clinical teams, estimating that 50% of post-operative complications are preventable¹.
Around 5 million surgical procedures are performed by United Kingdom’s NHS each year². During 2020-21 the number of surgical procedures fell by 1.5 million due to the COVID pandemic, adding to the record high of 7.4 million people on NHS treatment waiting lists³. Over 410,000 people have been waiting more than 1 year for treatment in the UK, which is 265 times as many as compared to before the COVID pandemic, and this number is expected to rise⁴.
This challenge is also repeated across the rest of Europe, Canada and USA. It will take many years to clear this backlog unless new solutions are found that increase the efficiency of surgical care pathways, particularly in pre-assessment to assess patient surgical fitness and plan their post surgical care.
In the UK the total cost to the NHS for re-admissions and treating complications is £13.7 billion. Asclepius MedTech Ltd. estimates that if the NHS commissioned the Asclepius Platform the result would be a 25% reduction in readmissions saving the UK NHS £300M per year.
- Geoffrey P. Dobson. Trauma of major surgery: A global problem that is not going away. International Journal of Surgery Volume 81, September 2020, Pages 47-54
- Royal College of Surgeons of England: Surgery and the NHS in Numbers. [Most recent data 2013/14/15]
- Dobbs TD, Gibson JAG, Fowler AJ et al. Surgical activity in England and Wales during the COVID-19 pandemic: a nationwide observational cohort study. BJA 2021; 127: 196-204
- British Medical Association. NHS Backlog Data Analysis. Dec 2022.
The Asclepius Platform is the first remote patient monitoring system for pre and post surgical assessment
Designed as remote service the Asclepius Platform has the potential to change the experience and outcomes for patients. Easily implementable it enables clinical and surgical teams to remotely assess the fitness of patients for surgery, predict surgical complications and help healthcare professionals plan better care for patients.
A safe and medically approved sensor patch is worn on the chest to record physiological data about the patient’s fitness. This data is combined with information from health questionnaires to estimate the risk of the patient suffering a surgical complication. Data transmitted in real-time and automated with cloud analytics is presented on the hospital team’s clinical dashboard. Analysis of combined multimodal data sets means patient care can be designed to minimise the risk of complications, reduce readmissions, and improve surgical efficiency. Which means that patients benefit from safer surgery, experience better outcomes and earlier discharge.
Hospitals and healthcare providers benefit from increased procedural efficiency and reduced costs with the remote monitoring nature of the platform increasing the productivity and capacity of hospitals to address their increasing demand for surgeries. It will contribute to hospital’s ‘net zero’ carbon objectives by reducing the number of clinic visits and patient care miles and is less impacted by workforce resource challenges.
Why we are investable
With significant funding from the National Institute of Health and Care Research (NIHR) and charitable bodies. A proof-of-concept study has demonstrated utility of the system in reliably capturing data from 50 patients undergoing major surgery with qualitative studies documenting acceptability to patients and clinicians. In collaboration with the NIHR Surgical Technologies MedTech Co-operative PPIE focus groups have facilitated a deeper understanding of the barriers to implementation and scalability, and requirements to address patient acceptability. A large observational clinical study, co-designed with PPIE, recruiting 200 patients was initiated in Dec 2022 and is currently evaluating the Asclepius Platform as a decision-support tool to assess patient fitness for surgery and to develop predictive algorithms.
Following additional funding from the National Institute of Health and Care Research (NIHR) April 2023 and investment from NLC European Healthtech Venture Builder July 2023 the next stage for the Asclepius Platform involves upgrading the clinical dashboard, app interface with the sensor and its app to record patient reported data to provide HCPs and surgical teams with comprehensive reports for enhanced decision-making.
This will be followed by the integration of validated cloud-based predictive algorithms and additional clinical research; supported by seed investment and non-dilutive grant funding.
Asclepius MedTech Ltd. plans a phased launch of its’ platform in the UK, EU and USA.
A large observational clinical study, co-designed with PPIE recruiting 200 patients was initiated in Dec 2022 and is currently evaluating the Asclepius Platform as a decision-support tool to assess patient fitness for surgery and to develop AI predictive algorithms..
Following a successful funding award from the National Institute of Health and Care Research (NIHR) in April 2023, the next stage for the Asclepius Platform involves upgrading the clinical dashboard, app interface with the sensor and its app to record patient reported data to provide HCPs and surgical teams with comprehensive reports for enhanced decision-making.
This will be followed by the integration of validated cloud-based predictive AI algorithms and additional clinical research; supported by seed investment and non-dilutive grant funding.
Asclepius MedTech Ltd plans a phased launch in the UK, EU and US markets.
News from Asclepius Medtech
Asclepius MedTech Limited: revolutionising pre-and post-operative surgical assessment by unleashing and unlocking the power of data
Asclepius MedTech Ltd. provides a remote patient monitoring platform set to revolutionise pre- and post-operative surgical assessment by unleashing and unlocking the power of data
The remote patient monitoring (RPM) market is experiencing significant growth, with a projected CAGR of 26.7%, attributed to the rising prevalence of chronic diseases. RPM
Under a new name, Academic Health Science Networks (AHSNs) are receiving continued support from the NHS and the government to drive innovation. Recognized as leaders
NHS Highland has introduced a digital pre-operative pathway to enhance patient care and streamline the surgical process. The new initiative leverages digital health technologies to
The global colorectal procedure market is projected to grow at a CAGR of 13.1% and reach $29.55 billion by 2028, as reported by The Insight
According to the Institute for Fiscal Studies, it is unlikely that NHS waiting lists will see substantial decreases in 2023. The report highlights the challenges
Spain is facing a dire situation as waiting lists for surgery hit an all-time high, with nearly 800,000 individuals in the queue. The record-breaking numbers
The NHS waiting list in England has reached a record-breaking 7.3 million, with little hope of significant cuts before the next general election. Despite promises
Become involved in our journey.
Please complete our contact form and we will be in touch shortly with Investor Information.
Please fill in the contact form and provide details of the scope of your research interest and we will be in touch shortly.
We are always interested to hear from patients to understand their views regarding our work and our technology. If you are willing to participate in patient research, please complete our contact form.